Sylvan M Sax

483 total citations
28 papers, 378 citations indexed

About

Sylvan M Sax is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Sylvan M Sax has authored 28 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Sylvan M Sax's work include Metabolism and Genetic Disorders (4 papers), Analytical Chemistry and Chromatography (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Sylvan M Sax is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), Analytical Chemistry and Chromatography (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Sylvan M Sax collaborates with scholars based in United States and Switzerland. Sylvan M Sax's co-authors include Klaus Hofmann, John J. Moore, Robert A. Lucas, Michael Welsh, George A. Jeffrey, Michael A. Marcus, Harry J. Lynch, Anthony R. Cillo, Ray H. Baughman and Jeffrey A. Silverman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Sylvan M Sax

28 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvan M Sax United States 10 169 46 44 38 29 28 378
M Royer United States 12 110 0.7× 27 0.6× 26 0.6× 40 1.1× 48 1.7× 26 426
Howard Ko United States 13 155 0.9× 26 0.6× 20 0.5× 41 1.1× 45 1.6× 25 469
S N Buhl United States 11 410 2.4× 27 0.6× 24 0.5× 24 0.6× 11 0.4× 22 674
Dale H. Altmiller United States 8 445 2.6× 53 1.2× 37 0.8× 49 1.3× 19 0.7× 17 775
D N Dietzler United States 15 252 1.5× 43 0.9× 32 0.7× 19 0.5× 15 0.5× 25 563
Esahak Ali India 11 202 1.2× 63 1.4× 8 0.2× 42 1.1× 20 0.7× 36 533
Lewis Siegel United States 11 338 2.0× 23 0.5× 65 1.5× 24 0.6× 35 1.2× 19 545
Jean Scholler United States 13 197 1.2× 46 1.0× 16 0.4× 26 0.7× 8 0.3× 43 423
Helene Thomsen Denmark 11 188 1.1× 49 1.1× 24 0.5× 26 0.7× 13 0.4× 25 355
Thomas D. Lockwood United States 13 197 1.2× 28 0.6× 20 0.5× 47 1.2× 18 0.6× 26 474

Countries citing papers authored by Sylvan M Sax

Since Specialization
Citations

This map shows the geographic impact of Sylvan M Sax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvan M Sax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvan M Sax more than expected).

Fields of papers citing papers by Sylvan M Sax

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvan M Sax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvan M Sax. The network helps show where Sylvan M Sax may publish in the future.

Co-authorship network of co-authors of Sylvan M Sax

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvan M Sax. A scholar is included among the top collaborators of Sylvan M Sax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvan M Sax. Sylvan M Sax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moore, John J., Michael A. Marcus, & Sylvan M Sax. (1982). Kinetic assay of beta-hydroxybutyrate in plasma with a COBAS-BIO centrifugal analyzer.. Clinical Chemistry. 28(4). 702–703. 17 indexed citations
3.
Sax, Sylvan M, et al.. (1979). Further observations on the incidence and nature of atypical creatine kinase activity.. Clinical Chemistry. 25(4). 535–541. 25 indexed citations
4.
Sax, Sylvan M, et al.. (1976). Atypical increase in serum creatine kinase activity in hospital patients.. Clinical Chemistry. 22(1). 87–91. 39 indexed citations
5.
Moore, John J. & Sylvan M Sax. (1972). Elimination of Dextran Interference in Serum Protein Determinations. Clinical Chemistry. 18(4). 393–394. 2 indexed citations
6.
Sax, Sylvan M, et al.. (1971). Determination of Serum and Urine Amylase with Use of Procion Brilliant Red M-2BS Amylopectin. Clinical Chemistry. 17(4). 311–315. 17 indexed citations
7.
Sax, Sylvan M & John J. Moore. (1970). Computer calculation of serum protein electrophoresis, based on peak height measurements.. PubMed. 16(9). 760–2. 1 indexed citations
8.
Moore, John J. & Sylvan M Sax. (1969). Serum Glutamic Oxalacetic Transaminase Assay Using the Sequential Multiple Analyzer (SMA 12/30). Clinical Chemistry. 15(8). 730–736. 4 indexed citations
9.
Sax, Sylvan M & John J. Moore. (1969). To the Editor:. Clinical Chemistry. 15(2). 177–177. 1 indexed citations
10.
Sax, Sylvan M & John J. Moore. (1967). Determination of Glutamic Oxalacetic Transaminase Activity by Coupling of Oxalacetate with Diazonium Salts. Clinical Chemistry. 13(3). 175–185. 12 indexed citations
11.
Sax, Sylvan M, et al.. (1966). Study of a recently proposed iron-sulfuric acid cholesterol method. Clinica Chimica Acta. 13(1). 79–90. 5 indexed citations
12.
13.
Sax, Sylvan M & John J. Moore. (1965). Fluorometric Measurement of Creatine Kinase Activity. Clinical Chemistry. 11(10). 951–958. 16 indexed citations
14.
Sax, Sylvan M & Harry J. Lynch. (1964). OXIDATION OF QUINOLINE BY RABBIT LIVER. Journal of Pharmacology and Experimental Therapeutics. 145(1). 113–121. 8 indexed citations
15.
Sax, Sylvan M, et al.. (1963). Factitious Hypoglycemia in Patients with Leukemia. American Journal of Clinical Pathology. 40(1). 43–45. 9 indexed citations
16.
Sax, Sylvan M, et al.. (1963). Factitiously Low Amylase Values. Clinical Chemistry. 9(3). 296–311. 3 indexed citations
17.
Sax, Sylvan M, Philip J. Migliore, & Ray H. Baughman. (1962). Preparation, analysis, and X-ray diffraction identification of barbiturate silver salts. Analytical Biochemistry. 3(2). 150–157. 2 indexed citations
18.
Hofmann, Klaus, et al.. (1959). A Synthesis of Cyclopropane-cis-1,2-diacetic Acid1-3. Journal of the American Chemical Society. 81(4). 992–997. 25 indexed citations
19.
Hofmann, Klaus & Sylvan M Sax. (1953). THE CHEMICAL NATURE OF THE FATTY ACIDS OF LACTOBACILLUS CASEI. Journal of Biological Chemistry. 205(1). 55–63. 42 indexed citations
20.
Hofmann, Klaus, Robert A. Lucas, & Sylvan M Sax. (1952). THE CHEMICAL NATURE OF THE FATTY ACIDS OF LACTOBACILLUS ARABINOSUS. Journal of Biological Chemistry. 195(2). 473–485. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Royer Breakdown of academic impact, for papers by Howard Ko Breakdown of academic impact, for papers by S N Buhl Breakdown of academic impact, for papers by Dale H. Altmiller Breakdown of academic impact, for papers by D N Dietzler Breakdown of academic impact, for papers by Esahak Ali Breakdown of academic impact, for papers by Lewis Siegel Breakdown of academic impact, for papers by Jean Scholler Breakdown of academic impact, for papers by Helene Thomsen Breakdown of academic impact, for papers by Thomas D. Lockwood
Rankless by CCL
2026